Read by QxMD icon Read


No abstract text is available yet for this article.
November 1949: Actualidad Médica
Sandra Puvacić, Mirsada Mulaomerović, Sead Karakas, Salih Tandir, Elijas Nada
Incidence rate of the harder adverse immunization reactions in the Program of the vaccination children in Federation Bosnia and Herzegovina is similar in the terms of kind and frequency as in the countries with high quality programme of the vaccination. In the period from 2002-2003 year cases of the adverse reactions were not registered, as vaccinal form of polyomyelitis, toxic syndrome or sudden acute deaths. The adverse events following immunization were classified in relation to 100,000 applicated vaccines, the incidence rate of supurative lymphadenitis at BCG vaccination reported are 32@100000, anaphylaxia at MMR vaccination 0...
2003: Medicinski Arhiv
(no author information available yet)
No abstract text is available yet for this article.
July 1953: Revista Médica del Hospital Español
J F Maillefert, I Tonolli-Serabian, A Cherasse, A L Demoux, C Tavernier, L Piroth
We describe 2 cases of arthritis following immunization against diphtheria, poliomyelitis and tetanus toxoid. One patient developed monoarthritis of the knee after immunization, that regressed following synovectomy. Five years later, the arthritis recurred after a booster vaccine injection. One day after immunization, another patient developed arthritis of the ankle that persisted for 3 days. It is difficult to know whether there is a coincidental or a causal relation between immunization and arthritis. Although our cases suggest that immunization against diphtheria, poliomyelitis and tetanus toxoid may cause arthritis, additional cases must be reported before studies aimed at confirming this possibility are considered...
March 2000: Clinical and Experimental Rheumatology
J J Gestal Otero, L Rodríguez Míguez, A Montes Martínez, B Takkouche
Vaccinations are considered to be one of the most protitable Public Health activities, given that almost three million deaths and four hundred thousand cases of polyomyelitis paralysis are avoided throughout the world every year. Nevertheless, in under-developed countries, especially Africa, two million children die every year from diseases that can be prevented by vaccination. This article studies the re-emergence in recent years of diphtheria in Eastern European countries (Ukrania, Russia, Belorussia, Poland, ...
January 1996: Revista Española de Salud Pública
S A Plotkin
Although each vaccine has limitations, both OPV and E-IPV have made a considerable contribution to the effective control of polyomyelitis. In view of the complementary advantages of the two vaccines, more use of their association in a common schedule is quite justified. An association of OPV and E-IPV, in which the latter is combined with DTP, seems particularly advantageous immunologically, logistically, and economically. There are several alternative ways in which the two vaccines could be associated sequentially or simultaneously...
0: Public Health Reviews
D Gionta, G Luccardi
No abstract text is available yet for this article.
March 1968: Annali Della Sanità Pubblica
T I Strokina
No abstract text is available yet for this article.
April 1967: Pediatriia
G Moya, L Martínez Fuertes, S Julián-Ramo
No abstract text is available yet for this article.
March 1970: Revista de Sanidad e Higiene Pública
C Oner
No abstract text is available yet for this article.
October 1965: Türk Tip Cemīyetī Mecmuasi
Z Kovács, D Ivánkievicz
No abstract text is available yet for this article.
August 1971: Stoma
H Bijkerk, F J Draaisma, T Landheer, M van Os
No abstract text is available yet for this article.
May 24, 1975: Nederlands Tijdschrift Voor Geneeskunde
G A Akimov, V S Lobzin, A A Mikhaĭlenko, A A Smorodintsev
The authors discuss some results of their study concerning the therapeutical effectiveness of different drugs and methods in treating herpes. A total of 194 patients were observed. In 73 cases desoxyribonuclease, interferon, inductors of interferon were used (viruses of ECHO of type 1 and 12, polyomyelitis vaccine, yeast ribonucleinic acid were used as inductors). Antiviral therapy permitted to prevent the development of postherpetic neuralgia, decrease the duration of hospitalization and in cases of remittent development either arrest or significantly reduce the number of relapses and clinical signs...
1978: Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova
E O Nightingale
Declining numbers of adequately vaccinated persons, new data about the comparative safety and effectiveness of live, attenuated and killed poliomyelitis-virus vaccines, increased consumer awareness of adverse reactions and pressure from manufacturers seeking protection from liability were factors leading the Institute of Medicine to re-examine poliomyelitis vaccination programs. The relative merits of live and killed virus vaccines as immunizing agents were reviewed within the context of the 60 to 70 per cent level of poliomyelitis vaccination now reached in the United States...
August 4, 1977: New England Journal of Medicine
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"